Medibank Private (MPL) Stock Price, News & Analysis

Company Overview

Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. The company underwrites its health insurance products under the Medibank and ahm brands. Medibank Private Limited was founded in 1976 and is based in Docklands, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 10.99 million shs
• Average Volume: N/A
• Market Capitalization: $10.88 billion
• P/E Ratio: 2,797.84
• Dividend Yield: 4.20%
• Price Target: N/A
• Consensus Rating: N/A

MPL Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Medibank Private own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medibank Private investors own include JD.com (JD), Dianthus Therapeutics (DNTH), Aflac (AFL), Advanced Micro Devices (AMD), Baidu (BIDU), Cameco (CCJ) and Citrix Systems (CTXS).

Company Calendar

• Ex-Dividend for 3/25 Dividend: 3/05/2025
• Record date for 3/25 Dividend: 3/25/2025
• Dividend Payable: 3/25/2025
• Today: 5/09/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Financial Services
• Industry: Insurance - Specialty
• Sub-Industry: N/A
• Current Symbol: ASX:MPL
• CIK: N/A
• Web: www.medibank.com.au
• Phone: 61 3 8622 5780
• Fax: N/A
• Employees: 3,242
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A$0.18
• Trailing P/E Ratio: 2,797.84
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $3.90 million
• Net Margins: 0.05%
• Pretax Margin: N/A
• Return on Equity: 0.17%
• Return on Assets: 10.38%

Debt

• Debt-to-Equity Ratio: 9.47
• Current Ratio: 13.03
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: $8.03 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 3.20
• Book Value: A$0.83 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,750,000,000
• Free Float: N/A
• Market Cap: $10.88 billion
• Optionable: Not Optionable
• Beta: 0.20